Staging laparoscopy in gastric cancer patients treated with curative intent: A European GASTRODATA cohort study

Background: In current guidelines, staging laparoscopy (SL) is recommended in patients with locally advanced gastric cancer (GC). This study aimed to assess the clinical practice of SL and its association with administration of systemic treatment in a European cohort of GC patients (GASTRODATA). Met...

Full description

Bibliographic Details
Authors: Sędłak, Katarzyna; Pera Román, Manuel; Rawicz-Pruszyński, Karol
Format: Article
Status:Accepted version
Publication date:2025
Country:España
Institution:Universitat Pompeu Fabra
Repository:Repositorio Digital de la UPF
OAI Identifier:oai:dnet:rdupf_______::7f23e7ff5d3808892cc3f85ea7a5b0b5
Online Access:https://hdl.handle.net/10230/72885
http://dx.doi.org/10.1245/s10434-025-17905-6
Access Level:Open access
Keyword:Gastric cancer
Multimodal treatment
Staging laparoscopy
_version_ 1878735492302766080
author Sędłak, Katarzyna
author2 Pera Román, Manuel
Rawicz-Pruszyński, Karol
author2_role author
author
author_browse Pera Román, Manuel
Rawicz-Pruszyński, Karol
Sędłak, Katarzyna
author_facet Sędłak, Katarzyna
Pera Román, Manuel
Rawicz-Pruszyński, Karol
author_role author
collection Repositorio Digital de la UPF
description Background: In current guidelines, staging laparoscopy (SL) is recommended in patients with locally advanced gastric cancer (GC). This study aimed to assess the clinical practice of SL and its association with administration of systemic treatment in a European cohort of GC patients (GASTRODATA). Methods: In this retrospective cohort study, patients with locally advanced GC who underwent multimodal treatment in 24 European centers were analyzed. Patients with early (cT1) or metastatic GC at diagnosis and those with missing data on chemotherapy administration were excluded. Results: Of 2558 patients, 1726 were selected, with 562 (32.6%) undergoing SL. Patients who did not undergo SL were older (72 vs. 65 years; p < 0.001) and had higher Charlson Comorbidity Index scores (- 2: 33.8% vs. 20.5%; p < 0.001). These patients had more complications (30.9% vs. 24.4%; p = 0.005), higher 90-day mortality (4.7% vs. 2.3%; p = 0.017), and were less likely to receive neoadjuvant (35% vs. 78.6%; p < 0.001) or adjuvant (27.1% vs. 33.8%; p = 0.005) chemotherapy. Non-SL patients had higher rates of serosal invasion (pT4: 38.0% vs. 26.0%; p < 0.001) and lymph node metastasis (63.5% vs. 60.4%; p = 0.004). Conclusions: SL was performed in one-third of individuals with locally advanced GC. Absence of SL was associated with higher T-stage discrepancy and decreased utilization of multimodal treatment.
eu_rights_str_mv openAccess
format article
id ES_7dc2fd2f5dc62b63fbec90fe2b34ba93
institution Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
network_acronym_str ES
network_name_str España
oai_identifier_str oai:dnet:rdupf_______::7f23e7ff5d3808892cc3f85ea7a5b0b5
publishDate 2025
publishDateSort 2025
publisher Springer
publisherStr Springer
reponame_str Repositorio Digital de la UPF
spelling Staging laparoscopy in gastric cancer patients treated with curative intent: A European GASTRODATA cohort study Sędłak, Katarzyna Pera Román, Manuel Rawicz-Pruszyński, Karol Gastric cancer Multimodal treatment Staging laparoscopy Background: In current guidelines, staging laparoscopy (SL) is recommended in patients with locally advanced gastric cancer (GC). This study aimed to assess the clinical practice of SL and its association with administration of systemic treatment in a European cohort of GC patients (GASTRODATA). Methods: In this retrospective cohort study, patients with locally advanced GC who underwent multimodal treatment in 24 European centers were analyzed. Patients with early (cT1) or metastatic GC at diagnosis and those with missing data on chemotherapy administration were excluded. Results: Of 2558 patients, 1726 were selected, with 562 (32.6%) undergoing SL. Patients who did not undergo SL were older (72 vs. 65 years; p < 0.001) and had higher Charlson Comorbidity Index scores (- 2: 33.8% vs. 20.5%; p < 0.001). These patients had more complications (30.9% vs. 24.4%; p = 0.005), higher 90-day mortality (4.7% vs. 2.3%; p = 0.017), and were less likely to receive neoadjuvant (35% vs. 78.6%; p < 0.001) or adjuvant (27.1% vs. 33.8%; p = 0.005) chemotherapy. Non-SL patients had higher rates of serosal invasion (pT4: 38.0% vs. 26.0%; p < 0.001) and lymph node metastasis (63.5% vs. 60.4%; p = 0.004). Conclusions: SL was performed in one-third of individuals with locally advanced GC. Absence of SL was associated with higher T-stage discrepancy and decreased utilization of multimodal treatment. Springer https://hdl.handle.net/10230/72885 http://dx.doi.org/10.1245/s10434-025-17905-6
spellingShingle Staging laparoscopy in gastric cancer patients treated with curative intent: A European GASTRODATA cohort study
Sędłak, Katarzyna
Gastric cancer
Multimodal treatment
Staging laparoscopy
status_str acceptedVersion
title Staging laparoscopy in gastric cancer patients treated with curative intent: A European GASTRODATA cohort study
title_full Staging laparoscopy in gastric cancer patients treated with curative intent: A European GASTRODATA cohort study
title_fullStr Staging laparoscopy in gastric cancer patients treated with curative intent: A European GASTRODATA cohort study
title_full_unstemmed Staging laparoscopy in gastric cancer patients treated with curative intent: A European GASTRODATA cohort study
title_short Staging laparoscopy in gastric cancer patients treated with curative intent: A European GASTRODATA cohort study
title_sort Staging laparoscopy in gastric cancer patients treated with curative intent: A European GASTRODATA cohort study
topic Gastric cancer
Multimodal treatment
Staging laparoscopy
topic_facet Gastric cancer
Multimodal treatment
Staging laparoscopy
url https://hdl.handle.net/10230/72885
http://dx.doi.org/10.1245/s10434-025-17905-6